Reducing stem cell variability with automation for standardized treatments: an interview with NYSCF's Scott Noggle
In this interview, Scott Noggle, Senior Vice President of Research at the New York Stem Cell Foundation Research Institute discusses why he is fascinated by stem cells and why variability in their production has hampered efforts to find new treatments.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.